321 related articles for article (PubMed ID: 7952424)
1. Regulation of tissue-type plasminogen activator-mediated fibrinolysis by plasminogen activator inhibitor type-1 in patients with ischaemic heart disease: possible unfavourable effect of diuretics.
Pedersen OD; Gram J; Bagger H; Keller N; Jespersen J
Coron Artery Dis; 1994 Jul; 5(7):617-23. PubMed ID: 7952424
[TBL] [Abstract][Full Text] [Related]
2. Does long-term angiotensin converting enzyme inhibition affect the concentration of tissue-type plasminogen activator-plasminogen activator inhibitor-1 in the blood of patients with a previous myocardial infarction.
Pedersen OD; Gram J; Jeunemaitre X; Billaud E; Jespersen J
Coron Artery Dis; 1997 May; 8(5):283-91. PubMed ID: 9285181
[TBL] [Abstract][Full Text] [Related]
3. Plasminogen activator inhibitor type-1 determines plasmin formation in patients with ischaemic heart disease.
Pedersen OD; Gram J; Jespersen J
Thromb Haemost; 1995 May; 73(5):835-40. PubMed ID: 7482412
[TBL] [Abstract][Full Text] [Related]
4. Fibrinolysis in patients with acute ischaemic heart disease. With particular reference to systemic effects of tissue-type plasminogen activator treatment on fibrinolysis, coagulation and complement pathways.
Munkvad S
Dan Med Bull; 1993 Sep; 40(4):383-408. PubMed ID: 8222763
[TBL] [Abstract][Full Text] [Related]
5. Plasminogen activator inhibitor activity in diabetic and nondiabetic survivors of myocardial infarction.
Gray RP; Patterson DL; Yudkin JS
Arterioscler Thromb; 1993 Mar; 13(3):415-20. PubMed ID: 8443145
[TBL] [Abstract][Full Text] [Related]
6. Sex differences in the determinants of fibrinolytic activity.
MacCallum PK; Cooper JA; Howarth DJ; Meade TW; Miller GJ
Thromb Haemost; 1998 Mar; 79(3):587-90. PubMed ID: 9531046
[TBL] [Abstract][Full Text] [Related]
7. Alterations in the fibrinolytic system components during acute myocardial infarction.
Ioannidou-Papayannaki E; Lefkos N; Boudonas G; Efthimiadis A; Psirropoulos D; Vogas V; Papadopoulos I; Klonizakis I
Acta Cardiol; 2000 Aug; 55(4):247-53. PubMed ID: 11041123
[TBL] [Abstract][Full Text] [Related]
8. Effects of captopril therapy on endogenous fibrinolysis in men with recent, uncomplicated myocardial infarction.
Wright RA; Flapan AD; Alberti KG; Ludlam CA; Fox KA
J Am Coll Cardiol; 1994 Jul; 24(1):67-73. PubMed ID: 8006284
[TBL] [Abstract][Full Text] [Related]
9. No influence of proinsulin and insulin on plasma levels of plasminogen activator inhibitor type 1 and tissue plasminogen activator in young women before and during intake of contraceptive steroids.
Petersen KR; Kjems LL; Skouby SO; Andersen LF; Jespersen J
Metabolism; 1996 Jul; 45(7):833-7. PubMed ID: 8692017
[TBL] [Abstract][Full Text] [Related]
10. The role of strict metabolic control by insulin infusion on fibrinolytic profile during an acute coronary event in diabetic patients.
Melidonis A; Stefanidis A; Tournis S; Manoussakis S; Handanis S; Zairis M; Dadiotis L; Foussas S
Clin Cardiol; 2000 Mar; 23(3):160-4. PubMed ID: 10761802
[TBL] [Abstract][Full Text] [Related]
11. Impairment of plasma fibrinolysis in young survivors of myocardial infarction with silent ischaemia.
Grzywacz A; Elikowski W; Psuja P; Zozulińska M; Zawilska K
Blood Coagul Fibrinolysis; 1998 Apr; 9(3):245-9. PubMed ID: 9663707
[TBL] [Abstract][Full Text] [Related]
12. Hyperfibrinolysis in alcoholic cirrhosis: relative plasminogen activator inhibitor type 1 deficiency.
Ferguson JW; Helmy A; Ludlam C; Webb DJ; Hayes PC; Newby DC
Thromb Res; 2008; 121(5):675-80. PubMed ID: 17870147
[TBL] [Abstract][Full Text] [Related]
13. Fibrinolytic activity in peripheral atherosclerosis in the elderly.
van der Bom JG; Bots ML; Haverkate F; Meyer P; Hofman A; Grobbee DE; Kluft C
Thromb Haemost; 1999 Feb; 81(2):275-80. PubMed ID: 10064006
[TBL] [Abstract][Full Text] [Related]
14. Laboratory evaluation of fibrinolysis in patients with a history of myocardial infarction.
Chandler WL; Stratton JR
Am J Clin Pathol; 1994 Aug; 102(2):248-52. PubMed ID: 8042597
[TBL] [Abstract][Full Text] [Related]
15. Behaviour of tissue plasminogen activator, plasminogen activator inhibitor 1 and their complex in various disease states.
Niwano H; Takahashi H; Tatewaki W; Wada K; Seki Y; Shibata A
Blood Coagul Fibrinolysis; 1992 Aug; 3(4):389-93. PubMed ID: 1420814
[TBL] [Abstract][Full Text] [Related]
16. Tissue plasminogen activator and plasminogen activator inhibitor-1 in stroke patients.
Lindgren A; Lindoff C; Norrving B; Astedt B; Johansson BB
Stroke; 1996 Jun; 27(6):1066-71. PubMed ID: 8650716
[TBL] [Abstract][Full Text] [Related]
17. Age dependence of blood fibrinolytic components and the effects of low-dose oral contraceptives on coagulation and fibrinolysis in teenagers.
Siegbahn A; Ruusuvaara L
Thromb Haemost; 1988 Dec; 60(3):361-4. PubMed ID: 3149043
[TBL] [Abstract][Full Text] [Related]
18. Plasma tissue plasminogen activator and plasminogen activator inhibitor-1 levels in acute myocardial infarction.
Ganti AK; Potti A; Yegnanarayan R
Pathophysiol Haemost Thromb; 2002; 32(2):80-4. PubMed ID: 12214153
[TBL] [Abstract][Full Text] [Related]
19. Serial changes in plasma concentration of plasminogen activator inhibitor-1 before and serially after thrombolytic therapy for acute myocardial infarction.
Goto S; Kawai Y; Handa S; Abe S; Takahashi E; Watanabe K; Hori S; Ikeda Y
Cardiology; 1993; 82(4):280-5. PubMed ID: 8402755
[TBL] [Abstract][Full Text] [Related]
20. The fibrinolytic system in the hemolytic uremic syndrome: in vivo and in vitro studies.
van de Kar NC; van Hinsbergh VW; Brommer EJ; Monnens LA
Pediatr Res; 1994 Aug; 36(2):257-64. PubMed ID: 7970942
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
